FDA’s Patient-Focused Drug Development Initiative Meeting

If you’ve received an organ transplant the Food and Drug Administration (FDA) wants to hear from you.  On September 27, 2016, FDA will hold its first to gain insight directly from patients about their experiences living with organ transplants and the medications they take to prevent organ rejection and manage related conditions.  This information will help FDA to consider issues important to patients when reviewing and considering approval of new therapies for transplant patients that may be developed in the future.  Input from these meetings will be incorporated into an official FDA report titled the Voice of the Patient.

If you are interested in participating live or via webcast here are the registration details: The public meeting will be held on September 27, 2016, from 9 a.m. to 5 p.m. Please register here for the meeting by September 20, 2016: http://organtransplantpfdd.eventbrite.com.

To keep up the momentum after the meeting, the National Kidney Foundation plans to submit written comments on this topic to FDA and we want to work with you to develop those comments. If you plan to attend the meeting either in person or via webinar, please email us at nkfadvocacy@kidney.org

You can learn more about the participation in this meeting and the questions you will be asked here: https://www.gpo.gov/fdsys/pkg/FR-2016-04-27/html/2016-09785.htm.

You can also find general information about the patient focused drug development initiative and the Voice of the Patient reports here: http://www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm368342.htm.

About nkf _advocacy

The National Kidney Foundation's advocacy movement is for all people affected by CKD, transplant candidates and recipients, living and potential donors, donor families and caregivers. We empower, educate and encourage you to get involved on issues relating to CKD, donation and transplantation.
This entry was posted in Uncategorized. Bookmark the permalink.

5 Responses to FDA’s Patient-Focused Drug Development Initiative Meeting

  1. Pingback: FDA’s Patient-Focused Drug Development Initiative Meeting | kidneystoriesblog

  2. Reblogged this on kidneystoriesblog and commented:
    Great post, I’m in how about you?

  3. I’m interested in participating

  4. Kathy Westhoff says:

    Sounds wonderful but I can’t participate on the 27th. How can I stay in touch with this. I received a kidney from my son almost 3 years ago.

  5. Gichia Gakuru Henry says:

    My daughter is a post kidney transplant patient and would like to read more on management and care of graft.

Your thoughts:

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s